Miki Horiguchi

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

Statistics in medicine

JCO precision oncology

Biometrics

JCO oncology practice

Dana Farber Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute

United States

Research Fellow :: Medical Oncology

Publications

Hajime Uno, Lu Tian, Miki Horiguchi, Satoshi Hattori, Kenneth L Kehl
Regression models for average hazard. Biometrics 80 (2) (2024)
Hajime Uno, Lu Tian, Miki Horiguchi, Satoshi Hattori, Kenneth L Kehl
Regression models for average hazard. Biometrics 80 (2) (2024)
Yushu Shi, Miki Horiguchi, Ying Lu
Suggestions on Using Machine Learning Models and Cautions for Analyzing Censored Time-To-Event Outcomes. JCO precision oncology 8 (2024)
Hajime Uno, Miki Horiguchi
Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis. JCO precision oncology 8 (2024)
Hajime Uno, Miki Horiguchi
Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis. JCO precision oncology 8 (2024)
Hajime Uno, Miki Horiguchi
Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis. JCO precision oncology 8 (2024)
Yushu Shi, Miki Horiguchi, Ying Lu
Suggestions on Using Machine Learning Models and Cautions for Analyzing Censored Time-To-Event Outcomes. JCO precision oncology 8 (2024)
Hajime Uno, Lu Tian, Miki Horiguchi, Satoshi Hattori, Kenneth L Kehl
Regression models for average hazard. Biometrics 80 (2) (2024)
Miki Horiguchi, Lu Tian, Hajime Uno
On assessing survival benefit of immunotherapy using long-term restricted mean survival time. Statistics in medicine (2023)
Miki Horiguchi, Lu Tian, Hajime Uno
On assessing survival benefit of immunotherapy using long-term restricted mean survival time. Statistics in medicine 42 (8) (2023)
Dame Idossa, Ana I Velazquez, Miki Horiguchi, Julia Alberth, Inas Abuali, Demetria Smith-Graziani, Gilberto de Lima Lopes, Sam Lubner, Narjust Florez
Mentorship Experiences Are Not All the Same: A Survey Study of Oncology Trainees and Early-Career Faculty. JCO oncology practice (2023)
Hajime Uno, Miki Horiguchi
Ratio and difference of average hazard with survival weight: New measures to quantify survival benefit of new therapy. Statistics in medicine 42 (7) (2023)
Hajime Uno, Miki Horiguchi
Ratio and difference of average hazard with survival weight: New measures to quantify survival benefit of new therapy. Statistics in medicine 42 (7) (2023)
Miki Horiguchi, Lu Tian, Hajime Uno
On assessing survival benefit of immunotherapy using long-term restricted mean survival time. Statistics in medicine 42 (8) (2023)
Hajime Uno, Miki Horiguchi
Ratio and difference of average hazard with survival weight: New measures to quantify survival benefit of new therapy. Statistics in medicine 42 (7) (2023)
Hajime Uno, Miki Horiguchi
Ratio and difference of average hazard with survival weight: New measures to quantify survival benefit of new therapy. Statistics in medicine (2023)
Miki Horiguchi, Hajime Uno
On permutation tests for comparing restricted mean survival time with small sample from randomized trials. Statistics in medicine 39 (20) (2020)
Hajime Uno, Miki Horiguchi, Michael J Hassett
Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes. The oncologist 25 (2) (2019)

Miki Horiguchi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Miki Horiguchi